A detailed history of Fiduciary Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Fiduciary Trust CO holds 7,184 shares of AZN stock, worth $462,936. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,184
Previous 7,071 1.6%
Holding current value
$462,936
Previous $551,000 1.45%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $8,663 - $9,901
113 Added 1.6%
7,184 $559,000
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $38,549 - $46,638
577 Added 8.89%
7,071 $551,000
Q1 2024

May 13, 2024

SELL
$61.03 - $69.57 $13,304 - $15,166
-218 Reduced 3.25%
6,494 $439,000
Q4 2023

Feb 12, 2024

BUY
$61.89 - $69.28 $27,726 - $31,037
448 Added 7.15%
6,712 $452,000
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $583 - $645
9 Added 0.14%
6,264 $424,000
Q2 2023

Aug 01, 2023

BUY
$69.91 - $75.81 $699 - $758
10 Added 0.16%
6,255 $447,000
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $129,646 - $146,994
-2,053 Reduced 24.74%
6,245 $433,000
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $6,234 - $8,100
115 Added 1.41%
8,298 $562,000
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $73,061 - $187,063
-1,378 Reduced 14.41%
8,183 $449,000
Q2 2022

Aug 12, 2022

SELL
$59.26 - $71.14 $3,259 - $3,912
-55 Reduced 0.57%
9,561 $632,000
Q1 2022

May 12, 2022

BUY
$55.72 - $67.12 $6,463 - $7,785
116 Added 1.22%
9,616 $638,000
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $5,726 - $6,765
-106 Reduced 1.1%
9,500 $554,000
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $73,617 - $80,546
1,325 Added 16.0%
9,606 $577,000
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $24,791 - $30,812
512 Added 6.59%
8,281 $496,000
Q4 2020

Jan 26, 2021

BUY
$48.52 - $58.02 $376,951 - $450,757
7,769 New
7,769 $389,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.